Dr. Goede on Obinutuzumab Versus Rituximab in CLL
December 8th 2013Valentin Goede, MD, from the University Hospital Cologne, discusses the efficacy findings from the stage 2 CLL11 study that examined obinutuzumab plus chlorambucil in patients with chronic lymphocytic leukemia with comorbidities.
Read More